Sort
39,280 grants matching “leukemia”
Cancer and Leukemia Group B
$390,841Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2012 · CA
Molecular Characterization of Acute Myeloid Leukemia
$390,820Irving Lerner Weissman · Stanford University · R01 · FY2012 · CA
Arsenic Trioxide Down-Regulates STAT3 Activity in AML
$390,806Roswell Park Cancer Institute Corp · R21 · FY2004 · CA
Immunogenetics of Outcomes Disparities after Allogeneic HCT
$390,800Effie W Petersdorf · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Novel Approaches for Antitumor and Antiviral Agents
$390,795Barry M Trost · Stanford University · R01 · FY2016 · GM
Principal Project
$390,792Shiv Subramaniam Pillai · Massachusetts General Hospital · U19 · FY2025 · AI
Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy
$390,792Ji-Xin Cheng · Boston University (Charles River Campus) · R33 · FY2023 · CA
Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases
$390,771Jeffrey Scott Mugridge · University Of Delaware · R35 · FY2025 · GM
Population-Based Assessment of Cancer Trial Generalizability in the Elderly
$390,756Elizabeth B Lamont · Harvard Medical School · R01 · FY2011 · CA
THYMOMA TYROSINE PROTEIN KINASE
$390,738Salk Institute For Biological Studies · R01 · FY2004 · CA
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
$390,734Jonathan D. Licht · University Of Florida · R01 · FY2020 · CA
Cohesin Mutations in Acute Myelogenous Leukemia
$390,712Sridhar Rao · Versiti Wisconsin, Inc. · R01 · FY2018 · CA
Chemoresistance and Stem Cell Selection
$390,687David A Williams · Boston Children'S Hospital · R01 · FY2009 · DK
PROJECT 9: STEM CELL FUNCTION & GENOME INSTABILITY IN LYMPHOMYELOID NEOPLASIA
$390,677Kevin D Mills · Mainehealth · P20 · FY2007 · RR
Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia
$390,664Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Staphylococcus Aureus Activation of TNF Signaling Pathways
$390,559Alice S Prince · Columbia University Health Sciences · R01 · FY2015 · HL
Leaders of Scientific Research Programs
$390,547Peter A Jones · University Of Southern California · P30 · FY2015 · CA
Immunogenetics of Outcomes Disparities after Allogeneic HCT
$390,521Effie W Petersdorf · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Understanding the niche of minimal residual disease leukemia cells
$390,486Yong-Mi Kim · Children'S Hospital Of Los Angeles · R01 · FY2019 · CA
UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP
$390,453University Of Colorado Denver · U10 · FY2002 · CA
EX VIVO EXPANDED CORD BLOOD CELLS
$390,382University Of Colorado Denver · R01 · FY2001 · CA
The PLZF Protein of t(11;17)-Promyelocytic Leukemia
$390,382Jonathan D. Licht · Icahn School Of Medicine At Mount Sinai · R01 · FY2006 · CA
Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes
$390,375Maria Eugenia Figueroa · University Of Michigan At Ann Arbor · R01 · FY2016 · HL
Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes
$390,375Maria Eugenia Figueroa · University Of Miami School Of Medicine · R01 · FY2017 · HL
The mechanisms of action of T-lymphocytes in neuropathic pain
$390,374Michael Costigan · Boston Children'S Hospital · R01 · FY2014 · NS